Alan Brown, MD
Cardiovascular Disease · Naperville, ILNPI 1386698694
Payments from drug & device makers
Across 832 payments — averaging $1815.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$738K
- Novartis$251K
- Regeneron Healthcare Solutions, Inc.$121K
- Esperion Therapeutics, Inc.$107K
- Amarin Pharma, Inc.$86K
- Sanofi-aventis U.S. LLC$53K
- plus $155K from 20 others
Across 3 payments — averaging $6350.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$19K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 414 | $738,232 |
| Novartis | 44 | $251,397 |
| Regeneron Healthcare Solutions, Inc. | 93 | $120,955 |
| Esperion Therapeutics, Inc. | 78 | $106,729 |
| Amarin Pharma, Inc. | 63 | $85,882 |
| Sanofi-aventis U.S. LLC | 36 | $52,862 |
| AstraZeneca | 12 | $45,812 |
| Regeneron | 18 | $29,497 |
| Astrazeneca UK Limited | 3 | $13,831 |
| Pfizer | 2 | $11,500 |
| Merck | 15 | $10,870 |
| Ionis Pharmaceuticals, Inc. | 8 | $9,498 |
| Medicure Pharma Inc. | 8 | $9,374 |
| Itamar Medical Inc | 5 | $6,894 |
| Akcea Therapeutics, Inc. | 3 | $5,475 |
| Kowa Pharmaceuticals America, Inc. | 3 | $4,266 |
| Kaneka Medical America LLC | 2 | $3,000 |
| Amryt Pharma Holdings Ltd | 1 | $2,150 |
| Eli Lilly | 15 | $2,083 |
| Abbott | 2 | $218 |
| Medtronic | 1 | $114 |
| Novo Nordisk | 1 | $87 |
| Boehringer Ingelheim | 1 | $58 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Boston Scientific | 1 | $26 |
| Chiesi USA, Inc. | 1 | $23 |
How this compares
$1,510,860 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Naperville
- Victor MarinescuNaperville$238K
- Sujith KalathiveetilNaperville$158K
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Steven LupovitchArlington Heights$2.6M
- Nitasha SarswatChicago$2M
- Alexander AdlerPeoria$1.5M
- Clifford KavinskyMaywood$1.4M
- Sanjiv ShahChicago$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.